Similarly, immunization with anti-PTH antibodies was effective in controlling hypercalcemia for more than 72 months in patients with unresectable parathyroid carcinoma in Phase III clinical trials [36], [37]. This evidence concerns the gene PTH and hypercalcemia disease.